Completed PHASE1 INTERVENTIONAL 2-arm NCT01036893

M0001 Effects on Oral Contraceptive Plasma Levels

The Effect of Prucalopride on the Plasma Levels of Oral Contraceptives (Ethinylestradiol and Norethisterone) in Healthy Subjects

Sponsor: FOCUS GmbH

Conditions Healthy Volunteers

Interventions prucalopride

Updated 5 times since 2017 Last updated: May 16, 2011 Started: Dec 31, 2009 Primary completion: Feb 28, 2010 Completion: May 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy Volunteers and is currently completed. FOCUS GmbH leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

FOCUS GmbH
Movetis

Data source: Movetis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Neuss, Germany